DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Author: Business Wire
Lineage Cell Therapeutics to Report Third Quarter 2020 Financial Results and Provide Business Update on November 4, 2020
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that it will report its th…
COVID-19 Impact: Contact Lenses Market Will Accelerate at a CAGR of over 6% through 2020-2024 | Demand for Disposable Contact Lenses to Boost Growth| Technavio
LONDON–(BUSINESS WIRE)– #ContactLensesMarket–The Global Contact Lenses Market will grow by USD 4.55 bn during 2020-2024
Santen and Aerie Conclude Exclusive License Agreement for Rhopressa® and Rocklatan® in Japan and Several Other Asian Countries
OSAKA, Japan & DURHAM, N.C.–(BUSINESS WIRE)–Santen Pharmaceutical Co., Ltd. (“Santen”) and Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”) announced that Santen and Aerie have entered into an exclusive development and commercialization agreement …
Gyroscope Therapeutics Announces First Patient Received Investigational Gene Therapy GT005 Via Orbit Subretinal Delivery System in Ongoing Phase I/II FOCUS Trial
LONDON–(BUSINESS WIRE)– #GeneTherapy–Gyroscope Therapeutics Announces First Patient Received Investigational Gene Therapy GT005 Via Orbit SDS in Ongoing Phase I/I FOCUS Trial.
Eyeglasses Market to Grow by over 7% in 2020, Carl Zeiss AG and De Rigo Spa Emerge as Key Contributors to growth | Technavio
LONDON–(BUSINESS WIRE)– #EyeglassesMarket–The Global Eyeglasses Market will grow by USD 41.98 bn during 2020-2024
iVeena Announces Positive Topline Results
SALT LAKE CITY–(BUSINESS WIRE)–iVeena is pleased to announce the topline results of its recently completed Phase 1/2a clinical trial, “A Randomized, Double-Masked, Trial of IVMED-80 Eyedrops for Treatment of Keratoconus.” The study objective was to d…
Aerie Pharmaceuticals to Announce Third Quarter 2020 Financial Results and Host Conference Call on Thursday, November 5, 2020
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Kala Pharmaceuticals Announces FDA Approval of EYSUVIS™ for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that the U.S. Food and…
Sunvera Group Continues Expansion in Metro Detroit
BINGHAM FARMS, Mich.–(BUSINESS WIRE)–Sunvera Group (“Sunvera”), a management services organization providing services to ophthalmology practices across multiple subspecialties and a Ridgemont Equity Partners portfolio company, announced the acquisiti…
National Vision Appoints Susan Somersille Johnson to Board of Directors
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE), one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, today announced the appointment of Susan Somersille Johnson, chief marketing o…
IVERIC bio to Report Third Quarter 2020 Financial Results and Host Conference Call on Monday, November 2, 2020
NEW YORK–(BUSINESS WIRE)–IVERIC bio today announced that it will report its third quarter 2020 financial and operating results on Monday, November 2, 2020.
Visus Therapeutics Expands Clinical Advisory Board With Appointment of Renowned Ophthalmologists
SEATTLE–(BUSINESS WIRE)– #presbyopia–Visus Therapeutics expands clinical advisory board with appointment of renowned ophthalmologists.
Insights on the Eye Health Supplements Global Market to 2027 – COVID-19 Impact and Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eye Health Supplements Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Ingredient Type, Indication, Cataract, Dry Eye Syndrome, and Others), Form, and Geography” report has been added to ResearchAndMarkets…
Ocular Therapeutix™ To Report Third Quarter 2020 Financial Results
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
MYAH gewinnt die angesehene Auszeichnung Silmo D’Or Award
CAPELLE AAN DEN IJSSEL, Niederlande–(BUSINESS WIRE)–Topcon Healthcare, ein führender Anbieter medizinischer Geräte und Softwarelösungen für die weltweite Gemeinschaft des Bereichs Augenheilkunde gab heute bekannt, dass sein Gerät zur Behandlungsplanu…
MYAH Wins Prestigious Silmo D’Or Award
CAPELLE A/D IJSSEL, The Netherlands–(BUSINESS WIRE)– #SeeingEyeHealthDifferently–Topcon Healthcare announced today that its MYAH myopia and dry eye management device has won the prestigious 2020 Silmo D’Or Award.
MYAH remporte le prestigieux prix Silmo d’Or
CAPELLE SUR L’YSSEL, Pays-Bas–(BUSINESS WIRE)–Topcon Healthcare, l’un des principaux fournisseurs de dispositifs médicaux et de solutions logicielles pour la communauté mondiale des soins oculaires, a annoncé aujourd’hui que son dispositif MYAH de ge…
MYAH gana el prestigioso premio Silmo D'Or
CAPELLE A/D IJSSEL, Países Bajos–(BUSINESS WIRE)–Topcon Healthcare, proveedor líder de dispositivos médicos y soluciones de software para la comunidad oftalmológica mundial, ha anunciado hoy que su dispositivo para la gestión de la miopía y el ojo se…
MYAH wint prestigieuze Silmo D’Or Award
CAPELLE AAN DEN IJSSEL, Nederland–(BUSINESS WIRE)–Topcon Healthcare, een vooraanstaande aanbieder van medische apparatuur en softwareoplossingen voor de globale oogheelkundige gemeenschap, heeft vandaag bekendgemaakt dat zijn MYAH apparaat voor myopi…